17 September 2021
News Category: 
News

The Royal Melbourne Hospital (RMH) researchers have received $17,480,419 in funding from the latest round of the National Health and Medical Research Council’s (NHMRC) grant announcements this week.

The latest round of funds help studies into cancer, diabetes, mental health, palliative care, iron deficiency, Alzheimer’s disease and Aboriginal and Torres Strait Islander Health.

A major winner from the latest round of announcements is the study On TRACK (Teaching, Research And Community Knowledges), which promotes better brain health for older Aboriginal and Torres Strait Islander Peoples.The study, led by RMH Geriatrician and University of Melbourne researcher Associate Professor Dina LoGiudice, received $3,000,000 in funding.

RMH Neurologist and Walter and Eliza Hall Institute of Medical Research’s Associate Professor Nawaf Yassi was also awarded $1,280,218 to further his study into the role of the Tau protein in the development of Alzheimer’s Disease.

The RMH congratulates all NHMRC recipients.

NHMRC RECIPIENTS

A/Pr Simon Rice - Pragmatic trial of a targeted digital intervention for youth with suicidal thoughts and behaviours attending outpatient care
Amount: $1,443,572

A/Pr Dina LoGiudice - On TRACK (Teaching, Research And Community Knowledges) : CRE promoting brain health with older Aboriginal and Torres Strait Islander peoples.
Amount: $3,000,000

Prof Wen Lim - IMPART - IMproving PAlliative care in Residential aged care using Telehealth
Amount: $1,047,058

Dr Sarah Price - Improving maternal metabolic health prior to pregnancy to prevent metabolic disease in the offspring
Amount: $650,740

A/Prof Daniel Steinfort - Improving survival in lung cancer using novel minimally invasive bronchoscopic techniques
Amount: $1,235,060

A/Prof Jo Robinson - Using social media to reduce suicide and self-harm in young people
Amount:$2,248,555

A/Prof Sant-Rayn Pasricha- Alleviating anaemia in mothers and babies worldwide
Amount: $2,398,844

Prof Clare Scott - Super-Responders and Super-Survivors – how to dramatically improve cancer outcomes
Amount: $2,372,570

A/Prof Nawaf Yassi - Tau - A diagnostic and therapeutic target in Alzheimer's Disease
Amount: $1,280,218

A/Pr John Wentworth - Combination immune therapy for type 1 diabetes
Amount: $1,803,802